Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies

Clinical trial NCT02507479 · UNKNOWN

Trial details

NCT number: NCT02507479
Sponsor: Sheba Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non Hodgkin Lymphoma Hodgkin Lymphoma Chronic Lymphocytic Leukemia Multiple Myeloma

Start date: 2015-09-01
Primary completion: 2017-07-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.